TP53 and cancer: The results were mostly enriched in the response group signaling pathways in cancer, NF-kB pathway, lymphocyte pathway, CD40 pathway, IL17, IL3, IL5, P53, ERK5, NO2IL12, ALK2 pathway, and cytokine linkage pathway.